Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Joel Marrs

Concepts (179)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
7
2022
372
1.610
Why?
Antihypertensive Agents
5
2021
429
1.600
Why?
Hypertension
7
2021
1059
1.500
Why?
Pharmacists
8
2023
236
1.450
Why?
Aspirin
3
2015
324
1.210
Why?
Platelet Aggregation Inhibitors
3
2015
400
1.120
Why?
Education, Pharmacy
6
2023
128
0.980
Why?
Text Messaging
2
2023
154
0.910
Why?
Diabetes Mellitus, Type 2
7
2017
2096
0.910
Why?
Atrial Fibrillation
2
2019
325
0.890
Why?
Cardiovascular Diseases
7
2022
1729
0.890
Why?
Anticoagulants
2
2019
547
0.870
Why?
Stroke
4
2019
1019
0.770
Why?
Thiophenes
2
2015
108
0.760
Why?
Allylamine
2
2012
7
0.730
Why?
Hypolipidemic Agents
3
2011
87
0.720
Why?
Internship, Nonmedical
2
2010
18
0.620
Why?
Medication Reconciliation
1
2018
25
0.600
Why?
Dyslipidemias
3
2019
154
0.540
Why?
Kidney Failure, Chronic
2
2011
488
0.520
Why?
Cholesterol, LDL
5
2019
307
0.500
Why?
Practice Guidelines as Topic
5
2019
1400
0.500
Why?
Pharmaceutical Services
2
2020
79
0.490
Why?
Heart Failure, Diastolic
1
2015
20
0.490
Why?
Ticlopidine
1
2015
56
0.480
Why?
Drug-Eluting Stents
1
2015
62
0.480
Why?
Thromboembolism
1
2015
94
0.480
Why?
Hypoglycemic Agents
2
2012
1008
0.470
Why?
Medically Underserved Area
1
2015
81
0.470
Why?
Blood Pressure
3
2016
1537
0.430
Why?
Piperazines
1
2015
313
0.420
Why?
Guideline Adherence
1
2016
490
0.420
Why?
Patient Discharge
2
2018
768
0.410
Why?
Urban Population
1
2015
402
0.410
Why?
Venous Thromboembolism
1
2015
231
0.400
Why?
Humans
43
2023
114925
0.400
Why?
Glucosides
1
2012
36
0.390
Why?
Thrombosis
1
2015
297
0.390
Why?
Anticholesteremic Agents
2
2012
128
0.370
Why?
Spironolactone
1
2010
28
0.360
Why?
Mineralocorticoid Receptor Antagonists
1
2010
38
0.360
Why?
Administration, Oral
3
2019
731
0.340
Why?
Preceptorship
1
2010
63
0.330
Why?
Professional Role
3
2020
152
0.320
Why?
Students, Pharmacy
1
2010
100
0.320
Why?
Medication Therapy Management
2
2020
67
0.310
Why?
Drug Therapy, Combination
4
2016
954
0.300
Why?
Schools, Pharmacy
3
2021
52
0.290
Why?
Benzodiazepines
1
2008
116
0.290
Why?
Angiotensin-Converting Enzyme Inhibitors
3
2021
180
0.290
Why?
Hypnotics and Sedatives
1
2008
134
0.280
Why?
Angiotensin Receptor Antagonists
2
2021
76
0.280
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2007
43
0.280
Why?
Hospitalization
2
2015
1754
0.280
Why?
Renal Dialysis
1
2010
369
0.280
Why?
Family Practice
2
2010
427
0.270
Why?
Sleep Initiation and Maintenance Disorders
1
2008
117
0.270
Why?
Insurance Coverage
1
2008
202
0.270
Why?
Certification
3
2013
89
0.270
Why?
Aged
10
2023
19120
0.260
Why?
Heart Failure
1
2018
1952
0.250
Why?
Poverty
1
2008
443
0.240
Why?
Faculty
2
2017
131
0.230
Why?
Ambulatory Care
1
2007
479
0.220
Why?
Social Identification
1
2023
50
0.210
Why?
Specialization
3
2013
115
0.210
Why?
Middle Aged
10
2023
26801
0.210
Why?
Reminder Systems
1
2023
162
0.190
Why?
Pharmacy
1
2021
29
0.190
Why?
Colesevelam Hydrochloride
2
2012
7
0.180
Why?
Pharmacy Service, Hospital
2
2013
84
0.180
Why?
Cell Phone
1
2021
77
0.180
Why?
Cardiovascular Agents
1
2021
125
0.170
Why?
Secondary Prevention
3
2016
221
0.170
Why?
Diabetes Mellitus
2
2020
904
0.170
Why?
Female
12
2021
59571
0.170
Why?
Retrospective Studies
6
2021
12543
0.170
Why?
Brain Ischemia
2
2013
299
0.170
Why?
Software
1
2023
537
0.170
Why?
Age Factors
2
2016
2891
0.160
Why?
Societies, Pharmaceutical
3
2021
27
0.150
Why?
Colorado
2
2023
4089
0.150
Why?
Blood Glucose
3
2012
1821
0.150
Why?
Heart Valve Diseases
1
2019
161
0.150
Why?
Male
10
2020
55655
0.140
Why?
Risk Factors
5
2019
8637
0.140
Why?
4-Hydroxycoumarins
1
2016
4
0.140
Why?
Clinical Trials as Topic
2
2012
934
0.140
Why?
Dissociative Disorders
1
2016
21
0.140
Why?
Community Participation
1
2017
116
0.140
Why?
Aged, 80 and over
4
2015
6363
0.140
Why?
Cholesterol
3
2019
368
0.140
Why?
Vitamin K
1
2016
42
0.140
Why?
Patient Transfer
1
2018
144
0.130
Why?
Primary Prevention
2
2014
171
0.130
Why?
Telemedicine
1
2022
665
0.120
Why?
Guidelines as Topic
1
2016
244
0.120
Why?
Adult
7
2021
30604
0.120
Why?
Blood Coagulation Disorders
1
2016
192
0.110
Why?
Treatment Outcome
2
2019
9105
0.110
Why?
Diuretics
2
2011
66
0.110
Why?
Suicide, Attempted
1
2016
313
0.110
Why?
Follow-Up Studies
3
2016
4427
0.110
Why?
Medication Adherence
2
2021
537
0.110
Why?
Emotional Intelligence
2
2023
7
0.100
Why?
Acute Disease
1
2015
915
0.100
Why?
Atherosclerosis
1
2015
342
0.100
Why?
United States
7
2021
12209
0.100
Why?
Data Collection
1
2014
623
0.100
Why?
Benzhydryl Compounds
1
2012
60
0.100
Why?
Health Promotion
1
2017
686
0.100
Why?
Hyperlipidemias
1
2012
122
0.090
Why?
Cross-Sectional Studies
1
2021
4406
0.090
Why?
Sex Factors
1
2016
1721
0.090
Why?
Continuity of Patient Care
1
2013
254
0.090
Why?
Universities
1
2013
339
0.090
Why?
Drug Resistance
1
2010
158
0.090
Why?
Interinstitutional Relations
1
2010
55
0.090
Why?
Pregnancy
1
2021
5525
0.080
Why?
Myocardial Infarction
1
2016
929
0.080
Why?
Drug Monitoring
1
2010
184
0.080
Why?
Coronary Artery Disease
1
2015
607
0.080
Why?
Advisory Committees
2
2021
208
0.080
Why?
Patient-Centered Care
1
2013
473
0.080
Why?
Emotions
2
2023
472
0.070
Why?
Receptors, GABA-A
1
2008
82
0.070
Why?
Dipeptidyl Peptidase 4
1
2007
10
0.070
Why?
Exercise
1
2017
1641
0.070
Why?
Adamantane
1
2007
16
0.070
Why?
Practice Patterns, Physicians'
1
2015
1177
0.070
Why?
Pyrrolidines
1
2007
55
0.070
Why?
Young Adult
4
2015
10476
0.070
Why?
Eicosapentaenoic Acid
1
2006
28
0.070
Why?
Hypertriglyceridemia
1
2006
34
0.070
Why?
Nitriles
1
2007
151
0.070
Why?
Aging
1
2016
1621
0.070
Why?
Docosahexaenoic Acids
1
2006
69
0.070
Why?
Insurance, Health
1
2008
244
0.070
Why?
Risk Assessment
2
2016
2975
0.070
Why?
Hyperglycemia
1
2009
292
0.060
Why?
Fatty Acids, Omega-3
1
2006
122
0.060
Why?
Animals
3
2012
31837
0.060
Why?
Triglycerides
1
2006
470
0.060
Why?
Patient Compliance
1
2008
526
0.060
Why?
Adolescent
4
2015
17826
0.060
Why?
Enzyme Inhibitors
1
2007
752
0.060
Why?
Pandemics
2
2022
1325
0.060
Why?
Sleep
1
2008
632
0.050
Why?
Curriculum
1
2006
845
0.040
Why?
Lipids
1
2022
582
0.040
Why?
Students
1
2023
499
0.040
Why?
Annual Reports as Topic
1
2017
5
0.040
Why?
Pragmatic Clinical Trials as Topic
1
2017
48
0.040
Why?
Organizational Policy
1
2017
68
0.040
Why?
Randomized Controlled Trials as Topic
1
2021
1215
0.030
Why?
Health Personnel
1
2021
574
0.030
Why?
Eating
1
2016
346
0.030
Why?
Clinical Competence
2
2011
901
0.030
Why?
Mechanical Thrombolysis
1
2013
5
0.030
Why?
Telephone
1
2013
152
0.030
Why?
Thrombolytic Therapy
1
2013
117
0.020
Why?
Adrenergic Antagonists
1
2011
9
0.020
Why?
Renin
1
2011
31
0.020
Why?
Angiotensin II Type 1 Receptor Blockers
1
2011
29
0.020
Why?
Phytotherapy
1
2011
66
0.020
Why?
Calcium Channel Blockers
1
2011
115
0.020
Why?
Drug Utilization
1
2011
167
0.020
Why?
Cohort Studies
1
2020
4903
0.020
Why?
Patient Care Management
1
2010
54
0.020
Why?
Hospitals, University
1
2010
171
0.020
Why?
Governing Board
1
2009
7
0.020
Why?
Prospective Studies
1
2020
6218
0.020
Why?
Length of Stay
1
2013
949
0.020
Why?
Databases, Factual
1
2013
1125
0.020
Why?
Patient Readmission
1
2013
608
0.020
Why?
Prevalence
1
2013
2251
0.020
Why?
Inpatients
1
2010
380
0.020
Why?
Drug Combinations
1
2006
286
0.020
Why?
Primary Health Care
1
2015
1515
0.020
Why?
Marrs's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)